has part
is_specified_input_of
is_manufactured_by
has role
immunizes host
Homo sapiens
Pentacel
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM109810.pdf
CVX: 120
vaccine
125145
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172502.htm
http://purl.bioontology.org/ontology/RXNORM/674453
674453
For active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease caused by Haemophilus influenzae type b when administered to infants and children 6 weeks through 4 years of age (prior to fifth birthday).
Pentacel
Kallan Roan, Oliver He
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine
protein of pathogen organism as vaccine component
Diphtheria-Tetanus-Pertussis-Poliovirus-Haemophilus b vaccine
USA licensed vaccine role
Canada licensed vaccine role
intramuscular vaccination
USA licensed vaccine
tetanus toxoid vaccine, inactivated
acellular pertussis vaccine, inactivated
diphtheria toxoid vaccine, inactivated
poliovirus vaccine inactivated, type 1 (Mahoney)
poliovirus vaccine inactivated, type 2 (MEF-1)
poliovirus vaccine inactivated, type 3 (Saukett)
Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine
Sanofi Pasteur Limited